SGE LSD9web.oie.int/RR-Europe/eng/Regprog/docs/docs/LSD9...Présentation PowerPoint Author: OIE...
Transcript of SGE LSD9web.oie.int/RR-Europe/eng/Regprog/docs/docs/LSD9...Présentation PowerPoint Author: OIE...
Standing Group of Experts on Lumpy Skin Disease in South East Europe
under the GF-TADs umbrella
SGE LSD9Athens, 16-17 October 2019
Report for [Turkey]
[Dr. Fahriye SARAÇ]
Standing Group of Experts on Lumpy Skin Disease in SE Europe under the GF-TADs umbrella
Lumpy Skin Disease occurrence in 2019
LSD outbreaks reported in 2019 (From 01/01/2019 until --/--/2019)
Region Number of
outbreaks
Period of occurrence
From
(date of 1st
outbreak)
To
( date of latest
outbreak)
Thrace 0 - -
Anatolia 131 04 January 09 October
TOTAL 131
Standing Group of Experts on Lumpy Skin Disease in SE Europe under the GF-TADs umbrella
Lumpy Skin Disease occurrence in 2019
Map of LSD outbreaks in 2019
Total : 131 outbreaks , 173 slaughter
Type of vaccine used (i.e. homologous/heterologous, if heterologous please provide dose per animal used )
Heterolog vaccineSheep and Goat Pox Bakırköy strain
5 doses
Number of doses used 15.659.718
Source of vaccines (e.g. national purchase , EU vaccine bank, other)
National purchase
Mode of vaccination(mandatory / voluntary)
Mandatory
Area of vaccination : ( e.g. whole country, ring vaccination around outbreaks , specific regions –explain if needed)
Whole country
Comments – other info(if any)
Lumpy Skin Disease Vaccination in 2019
Standing Group of Experts on Lumpy Skin Disease in SE Europe under the GF-TADs umbrella
Lumpy Skin Disease Vaccination in 2019
Standing Group of Experts on Lumpy Skin Disease in SE Europe under the GF-TADs umbrella
LSD vaccination in 2019 (From 01/01/2019 until --/--/2019)
Region Total cattle %
vaccinati
on
coverage
Period of vaccination
PresentVaccinat
ed
From
(start date)
To
( end date)
Thrace 639.000 632.839 99,03 1 January1
September
Anatolia16.085.
155
15.026.8
7993,42 1 January
1
September
TOTAL16.724.
155
15.659.7
1893,63
• Standing Group of Experts on LSD in Europe under the GF-TADs umbrella
4 055 640
8 574 483
11 575 561
13 864 387
15 048 367 15 659 718
0
2 000 000
4 000 000
6 000 000
8 000 000
10 000 000
12 000 000
14 000 000
16 000 000
18 000 000
2014 2015 2016 2017 2018 2019
Number of Vaccinated Cattles
Lumpy Skin Disease Vaccination in 2019
Standing Group of Experts on Lumpy Skin Disease in SE Europe under the GF-TADs umbrella
Map of LSD vaccination areas and vaccine coverage in 2019
• Standing Group of Experts on LSD in Europe under the GF-TADs umbrella
• LSD control strategy of Turkey is based on Veterinary Services, Plant Health, Food and Feed law no: 5996 and in compliance with Council Directive 92/119/EEC except slaughtering.
• LSD is compulsory notifiable disease in Turkey.• Restriction, Quarantine, Ring Vaccination, Sampling, Diagnosis
Control of animal movements Cleaning and Disinfection in outbreak areas, Insect control, Vaccination in outbreak area.
• National Reference Laboratory is Pendik Veterinary Control Institute
• SGP vaccine (Bakırkoy strain, local strain) is used for LSD that produced by PVCI and two private companies.
• Positive laboratory result and clinically symptomatic animals in outbreak zone compensated to the owners (100% of the animal value)
LSD Control Program in 2019
• Standing Group of Experts on LSD in Europe under the GF-TADs umbrella
LSD Control Program in 2019
• The vaccination campaign carried out between 1 January – 1 September
• Due to different climatic conditions of the regions, each province directorate organised the time of ownvaccination program(because of the differences between their climate conditions, geographical status and husbandry system)
• All cattles older than 3 months were vaccinated with5 times sheep and goat pox vaccine (Bakirkoy Strain)
Lumpy Skin Disease surveillance in 2019
Standing Group of Experts on Lumpy Skin Disease in SE Europe under the GF-TADs umbrella
Type of surveillance implemented
1. Passive Clinical SurveillanceClinical examination and sampling after notification of a
suspicion on LSD by farmers/private vets
2. Active Clinical Surveillance in Outbreak AreasClinical examination in at least 10 km diameter zone
(protection and surveillance zone) in the case of an LSD confirmation
Lumpy Skin Disease surveillance in 2019
Standing Group of Experts on Lumpy Skin Disease in SE Europe under the GF-TADs umbrella
Type of surveillance implemented
3. Risk Based Surveillance Program in Thrace RegionStatistical target: to detect a herd prevalence of 5% and prevalence within theherds of 5% LSD for detecting the clinical signs among susceptible animals of each epidemiological unit with a 95% level of confidence).Number of epi-units to be sampled distributed propotion number of totalnumber of villages per province by expected prevalance;Çanakkale:33;Istanbul:43;Edirne:53;Kırklareli:52 andTekirdağ:55)
In total 236 epi units, clinical surveillance is conducted in everycycle. 4 cycles are realized a year.
Lumpy Skin Disease surveillance in 2019
Standing Group of Experts on Lumpy Skin Disease in SE Europe under the GF-TADs umbrella
Number examined Outcome
Number of LSD suspicions investigated
214 131 positive results
Number of holdings subject to LSD clinical examination
-709 holdings in Thrace(RBS)
-64.660 holdings in outbreaks zone
Samples were taken from suspected
animals of LSD. No positive results found
Number of animals subject to LSD clinical examination
-42.480 animals in Thrace (RBS)
-581.940 animals in outbreaks zone
Samples were taken from suspected
animals of LSD. No positive results found
Number of Samples subject to LSD serology (e.g. ELISA , SNT other) - -
Number of Samples subject to LSD virological tests (e.g. PCR, other) 214 131
Comments – other info (if any)
• Standing Group of Experts on LSD in Europe under the GF-TADs umbrella
• Detection of vectorborn diseases and creation of earlywarning system in Turkey
• Addressing the dual emerging threats of African Swine Feverand Lumpy Skin Disease in Europe DEFEND (EU Project)
• Enhancing national capabilities for early and rapid detectionof priority vector borne diseases of animals (includingzoonoses) by means of molecular diagnostic tools (IAEAProject)
• Control and prevention of Lumpy Skin Disease (LSD) (EUfunded IPA Project)
Ongoing Projects
Lumpy Skin Disease planning for 2020 (e.g. LSD vaccination/surveillance , if any)
• Standing Group of Experts on LSD in Europe under the GF-TADs umbrella
IPA Project «Control and prevention of Lumpy Skin Disease (LSD)» financed by EU
Contracts of the project:
• 1- Technical Asistance for Control and Prevention of Lumpy Skin Disease
• 2- Supply of Vaccines for Control and Prevention of Lumpy Skin Disease
• 3- Supply of Laboratory Equipment and Light Traps for Control andPrevention of Lumpy Skin Disease
Lumpy Skin Disease planning for 2020 (e.g. LSD vaccination/surveillance , if any)
• Standing Group of Experts on LSD in Europe under the GF-TADs umbrella
1- Technical Asistance for Control and Prevention of Lumpy Skin Disease
Targets :
• a) Improvement of diagnostic methods for LSD
• b) Capacity building of MoAF staff via trainings
• c) To raise the livestock farmers’ awareness on LSD
• d) To develop Animal Health Strategy of MoAF for LSD
Lumpy Skin Disease planning for 2020 (e.g. LSD vaccination/surveillance , if any)
• Standing Group of Experts on LSD in Europe under the GF-TADs umbrella
• Target : To supply both homologous and heterologous vaccine for 3 years(2020-2022)
2- Supply of Vaccines for Control and Prevention of LumpySkin Disease
Lumpy Skin Disease planning for 2020 (e.g. LSD vaccination/surveillance , if any)
• Standing Group of Experts on LSD in Europe under the GF-TADs umbrella
3-Supply of Laboratory Equipment and Light Traps for Control and Prevention of Lumpy Skin Disease
Target :
• a) To increase the equipment capacity of diagnostic laboratories
• b) To supply light traps to investigate the vector activity in thecountry
Lumpy Skin Disease planning for 2020 (e.g. LSD vaccination/surveillance , if any)
THANK YOU
• Standing Group of Experts on LSD in Europe under the GF-TADs umbrella